Functional analysis of the CD8+CD57+ cell population in normal healthy individuals and matched unrelated T‐cell‐depleted bone marrow transplant recipients

The biological activities of CD8+ that co‐express CD57 remain poorly defined. It is unclear whether all CD8+ cells have the potential to become CD57+ or whether they represent a unique subset with distinct functions. Several studies have reported the association between elevated numbers of CD8+CD57+ and a wide range of clinical disorders such as viral reactivation of human cytomegalovirus (HCMV). In this study, we have investigated the relationship between viral reactivation and the effect of diminished interleukin (IL)‐2 production. Using CD8+ cells isolated from patients at various times after allogeneic transplants and in vitro models of HCMV infection, we determined their combined effect on CD8+CD57+. Our results show that high numbers of CD8+CD57+ correlated with diminished killing of HCMV‐infected targets. In addition, we showed a synergistic effect between IL‐2 and HCMV in the expansion of CD8+CD57+ cells. Furthermore, these cells after anti‐CD3 stimulation did not produce tumour necrosis factor (TNF)‐α or interferon (IFN)‐γ. Interestingly, IL‐10 production was elevated in several patients which appeared to be associated with the time from transplant.

[1]  Lepper,et al.  Interleukin‐10‐induced CD8 cell proliferation , 1999, Immunology.

[2]  J. Hancock,et al.  The use of Teflon cell culture bags to expand functionally active CD8+ cytotoxic T lymphocytes. , 1999, Journal of immunological methods.

[3]  M. Hazzan,et al.  Recall response to cytomegalovirus in allograft recipients: mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28- cells within the CD8+ T lymphocyte compartment. , 1997, Transplantation.

[4]  H. Ostrer,et al.  Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. , 1996, Journal of immunology.

[5]  H. Volk,et al.  The enigma of CD57+CD28– T cell expansion—anergy or activation? , 1996, Clinical and experimental immunology.

[6]  P. Lehner,et al.  CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. , 1995, Journal of immunology.

[7]  F. Preijers,et al.  Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection , 1995, British journal of haematology.

[8]  P. Lehner,et al.  CD8high(CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein‐Barr virus‐transformed B cell lines , 1994, European journal of immunology.

[9]  B. Autran,et al.  An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients , 1994, European journal of immunology.

[10]  T. Rème,et al.  CD57+ T lymphocytes are derived from CD57− precursors by differentiation occurring in late immune responses , 1994, European journal of immunology.

[11]  J. Rodgers,et al.  Anergy and apoptosis in CD8+ T cells from HIV-infected persons. , 1994, Journal of immunology.

[12]  C. Katlama,et al.  A lectin‐binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity , 1991, European journal of immunology.